Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

GE HealthCare Technologies Q3 2026 Results: Net Income $615M, Up 37.9% YoY

For the three months ended September 30, 2026, GE HealthCare reported total revenues of $5.5 billion, a 7% increase compared to the prior year, and net income attributable to the company of $615 million. The company's nine-month performance showed steady growth with net income reaching $1.56 billion, while the balance sheet reflected a significant increase in goodwill to $15.1 billion following acquisition activities.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue5,513.05,143.0
Gross profit2,224.01,990.0
Profit before tax752.0643.0
Net income615.0446.0
EPS (diluted, $ a share)$1.36$0.98

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+37.9%
Revenue, year on year+7.2%
Gross margin40.3%
Operating margin14.6%
Source

10-Q filed with the SEC, NASDAQ: GEHC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

GE HealthCare Technologies Inc.: key numbers

Share price
$81.84Close, Nov 17
Market cap
$37B
Shares outstanding
452.14MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
X-Ray Apparatus & Tubes & Related Irradiation ApparatusSIC 3844

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from GE HealthCare Technologies Inc.

All →
8:45 AM ET 8-K
Leadership Change

GE HealthCare Technologies Leadership Change

Taha Kass-Hout notified GE HealthCare Technologies Inc. of his resignation as Chief Science and Technology Officer on November 4, 2026. His departure is effective December 31, 2026.

6:26 AM ET 8-K
Financial Results

GE HealthCare Technologies Financial Results

GE HealthCare reported third quarter 2026 financial results with revenue growth of 7.2% to $5.5 billion and raised its full-year guidance. The company also announced that Jeannette Bankes will resign as President and CEO of Patient Care Solutions, to be succeeded by Neal Sandy on November 16, 2026.

“We delivered strong top-line growth and margin expansion across all segments, and robust EPS growth in the third quarter. This reflects our teams’ commercial execution, disciplined operational focus enabled by Heartbeat, and continued customer adoption of our innovations. With our improved performance year-to-date and momentum in the business, we are raising guidance for the year.”

Peter Arduini, GE HealthCare President and CEO
4:08 PM ET 8-K
Leadership Change

GE HealthCare Technologies Leadership Change

GE HealthCare Technologies Inc. has appointed Pascal Desroches, the current CFO of AT&T, to its Board of Directors effective January 4, 2027. Mr. Desroches will also serve on the Audit and Talent, Culture, and Compensation Committees, bringing over 30 years of experience in finance and corporate strategy to the board.

Counterparty
Pascal Desroches

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.